In today’s episode Professor Eric Morand discusses the results of Cohort A and Cohort B of the WILLOW trial which investigated the efficacy and safety of enpatoran, a novel, oral small molecule inhibitor of Toll-like receptors 7 and 8 (TLR 7/8) in patients with cutaneous lupus erythematosus (CLE) and systemic lupus erythematosus (SLE). The interferon pathway ... Show More
Apr 21
Dirk Foell on trends in paediatric rheumatology care across Europe
In this episode, Professor Dirk Foell from University Hospital Münster unpacks the findings from a recent Europe-wide survey examining trends in paediatric rheumatology care. Despite significant scientific advances, delivering consistent, high-quality care for children with rheum ... Show More
16 m
<p>Host: Darryl S. Chutka. M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Ashima Makol, M.B.B.S.</p>
<p>Guest: Matthew J. Koster, M.D.</p>
<p>Rheumatologic problems are some of the most common health conditions we see as primary care professionals. I ... Show More
